Novartis AG NVS:NYSE (Depositary Receipt)

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
90.76 1.03   1.15%3.08%1,291,6181.6M
Market data is delayed by at least 20 minutes.
Summary chart showing the current equity's performance of over the past 1 days
  • Advanced Charts
  • Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

Market is closed. As of 03:59 PM ET 10/8/2014

Latest News Headlines for Novartis AG

Technical Updates on Health Care Sector Stocks - AstraZeneca, Novartis, Salix Pharma, Inovio Pharma, and CTI BioPharma

Editor Note: For more information about this release, please scroll to bottom. LONDON, October 6, 2014 /PRNewswire/ -- Investor-Edge has initiated coverage on the following equities: AstraZeneca PLC (NYSE: AZN), Novartis AG (NYSE: NVS), Salix Pharmaceuticals Ltd. (NASDAQ: SLXP), Inovio Pharmaceuticals Inc. (NASDAQ: INO), and CTI BioPharma Corporation (NASDAQ: CTIC). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Friday, October 03, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,009.69, up 1.24% and the NASDAQ Composite closed at 4,475.62, up 1.03%. The S&P; 500 finished the session 1.12% higher at 1,967.90. During the trading session, all the ten sectors finished on a higher note. The S&P; 500 Health Care Sector Index ended the day at 745.09, up 1.97%, with the index advancing 3.29% in the previous three months. Register for your complimentary reports on these five stocks at:

View more recent headlines

Company Background

Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. Its portfolio includes medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. It has five segments: Pharmaceuticals, which include patent-protected prescription medicines; Alcon, which include surgical, ophthalmic pharmaceutical and vision care products; Sandoz, which include generic pharmaceuticals; vaccines and diagnostics, which include human vaccines and blood-testing diagnostics, and consumer health, which include over-the-counter medicines (OTC) and Animal Health. In February 2014, it acquired CoStim Pharmaceuticals, Inc.

http://www.novartis.com

Loading...

collapse, right-facing arrow indicating collapsed view of sectionOverview

A table providing an overview of the stock
Bid | Size-- | --
Ask | Size-- | --
Price Open88.95
Previous Close89.73
Day High90.83
Day Low88.93
52 Week High9/17/2014 | 95.50
52 Week Low10/10/2013 | 72.77
% Off 52 Week High(4.96)%
% Off 52 Week Low24.72%
Beta (5 Yr)0.53
Volatility Avg10/7/2014 | 15.58
10-Day Avg. Volume1,573,429
Market data is delayed by at least 20 minutes.

collapse, right-facing arrow indicating collapsed view of sectionFundamentals

A table providing the fundamentals of the stock
EPS (TTM)6/30/2014 | 3.79
P/E Ratio6/30/2014 | 23.7
Market CapMega Cap | 222.1B
Shares Outstanding2.45B
Float412.8M

collapse, right-facing arrow indicating collapsed view of sectionDividends

A table providing information about the dividends of the stock
Dividend Yield3.08%
Ex-Date2/27/2014
Dividend Announcement2/3/2014
Date of Record3/3/2014
Payable$2.7598 - ANN
Payable Date4/10/2014

collapse, right-facing arrow indicating collapsed view of sectionShare Statistics

A table providing statistics about shares of the stock
Shares Short2.02M
Short Ratio1.3
Short % of Float0.49%
As of 9/15/2014

Peers Information HelpNVS Novartis AG vs. Peers

Peers 
NVS
Novartis AG
11.63%
Johnson & Johnson
11.79%
Pfizer Inc.
-6.01%
Merck & Co., Inc.
16.80%
Abbott Laboratories
8.17%
NVS
Novartis AG
3.04%
Johnson & Johnson
2.73%
Pfizer Inc.
3.61%
Merck & Co., Inc.
3.01%
Abbott Laboratories
2.12%
NVS
Novartis AG
1.15%
Johnson & Johnson
2.46%
Pfizer Inc.
2.05%
Merck & Co., Inc.
2.94%
Abbott Laboratories
1.64%
Compare these stocks